Phase 2 Study of Pemetrexed in Combination With Carboplatin or Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin; Cetuximab; Cisplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2013 Planned End Date changed from 1 Aug 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 18 Jan 2013 Planned end date changed from 1 Feb 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.